Atlas Trials

A Phase III Clinical Trial Assessing the Immunogenicity and Safety of Lyophilized Live-Attenuated Varicella Vaccine in Healthy Subjects Aged 13 to 55 Years

Clinical trial NCT06592456 · COMPLETED

Trial details

NCT number
NCT06592456
Sponsor
Southeast University, China
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chickenpox Vaccines
Start date
2019-07-21
Primary completion
2021-10-07
Enrollment
1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.